HOME >> MEDICINE >> NEWS
New guideline: Corticosteroids recommended for duchenne muscular dystrophy

ST. PAUL, Minn. Corticosteroids can be beneficial in the treatment of Duchenne muscular dystrophy and can be offered as a treatment option, according to the American Academy of Neurology and the Child Neurology Society in a new practice guideline published in the January 11 issue of Neurology, the scientific journal of the American Academy of Neurology.

Duchenne muscular dystrophy is a genetic disorder linked to the X-chromosome. It is the most common form of muscular dystrophy in children and occurs when the protein dystrophin is missing. This causes a gradual breakdown of muscles and a decline in muscle strength. Duchenne muscular dystrophy mainly affects boys. An estimated one in 3,500 males worldwide has the disorder, and each year approximately 400 boys in the United States are born with it. Symptoms usually appear between ages two and five and include frequent falls, large calf muscles, and difficulty running, jumping, and getting up. There is no cure.

The guideline authors reviewed all available research for the use of corticosteroids in the treatment of Duchenne muscular dystrophy. Corticosteroids are man-made drugs that are similar to the body's hormone cortisone. Two corticosteroids, prednisone and deflazacort, were found to slow the rate of muscle deterioration, and are recommended as potential treatments to minimize the effect of Duchenne muscular dystrophy.

Prednisone was found to help muscle strength and function and should be offered as a treatment option. Deflazacort, a drug similar to prednisone, is also recommended as a treatment option but is not available in the United States at this time.

"Corticosteroids are the only effective drugs in providing improvements in children with Duchenne muscular dystrophy," said lead author Richard T. Moxley III, MD, of the University of Rochester in Rochester, N.Y.

The guideline authors caution that an offer of treatment with corticosteroids should include a balan
'"/>

Contact: Marilee Reu
mreu@aan.com
651-695-2789
American Academy of Neurology
10-Jan-2005


Page: 1 2

Related medicine news :

1. Concern about pain reliever side effects, many patients take more than recommended
2. Reduced risk for developing type 2 diabetes recommended for inclusion in Xenicals European label
3. Even though it prevents fracture, HRT not recommended, say Pittsburgh researchers
4. People with chronic eye diseases not getting recommended eye exams
5. Most Canadian hospitals below recommended standards
6. Millions of Americans are failing to get recommended health care
7. Initially recommended drug dosages often too high, study finds
8. Study finds half of rape survivors do not receive recommended medical treatment
9. American kids poor food choices: Fewer than 15 percent eat recommended fruits and vegetables
10. New strategy recommended to combat hepatitis
11. Food should be fortified with folic acid to ensure all mothers receive recommended daily requirements

Post Your Comments:
(Date:5/28/2015)... lifeIMAGE announced today that ... led by Cambia Health Solutions (Portland, Ore.), ... health care by creating a person-focused and economically sustainable ... for exchanging medical imaging, will use this financing to ... breadth of its network capabilities and implement the next ...
(Date:5/28/2015)... 2015 WebWatcher, the leading ... partnership with BeSure Consulting to help parents ... The partnership will combine BeSure Consulting’s online ... monitoring software solution. , Led by Internet ... passion is concentrated on teaching law enforcement ...
(Date:5/28/2015)... 2015 A bucket list should include ... Each item on the bucket list can be tiny, ... tasks that the owner wants to happen in their ... when it comes to making this list. Bucket ... publishing a book, seeing the Grand Canyon on horseback, ...
(Date:5/28/2015)... what your racquet can do for you but what kind ... the launch of their new digital campaign, HEAD introduces trick ... unique skill to HEAD Pro Players and consumers around the ... demonstrates how to gain more control over the racquet and ... tennis enthusiasts everywhere to join the show. , The digital ...
(Date:5/28/2015)... The MIT Sloan Center for Information ... IQ. Members of the MIT CISR research team interviewed ... develop the case study about Healthcare IQ’s business model ... case study, ‘Healthcare IQ: Competing as the “Switzerland” of ... as a hospital financial software provider through its evolution ...
Breaking Medicine News(10 mins):Health News:Cambia Health Solutions Leads New Round of Investment in lifeIMAGE 2Health News:Cambia Health Solutions Leads New Round of Investment in lifeIMAGE 3Health News:Cambia Health Solutions Leads New Round of Investment in lifeIMAGE 4Health News:WebWatcher Partners with BeSure Consulting 2Health News:WebWatcher Partners with BeSure Consulting 3Health News:Tennis Artist Baffles Novak Djokovic - HEAD Launches Trick Shot Campaign “Frame & Play” 2Health News:Healthcare IQ, the “Switzerland” of Healthcare Spend Analytics, Featured in MIT Case Study 2Health News:Healthcare IQ, the “Switzerland” of Healthcare Spend Analytics, Featured in MIT Case Study 3
(Date:5/28/2015)... -- A new report by Allied Market ... Opportunities, Growth and Forecast, 2014-2020", forecasts the global syphilis ... secondary syphilis testing would continue to be the largest ... , Middle East & ... 43% revenue share of the global syphilis testing market ...
(Date:5/28/2015)...  The recent flurry of PBM mergers and ... scrambling to identify a pharmacy benefit manager that ... retail pharmacy chain, or other potentially conflicting entity. ... Catamaran, Rite Aid,s $2 billion acquisition of EnvisionRx, ... $10 billion are just the latest examples of ...
(Date:5/28/2015)... WASHINGTON , May 28, 2015 ... resolving the Commission,s antitrust suit charging Cephalon, Inc. ... sleep-disorder drug Provigil. The settlement ensures that Teva ... will make a total of $1.2 billion available ... insurers, who overpaid because of Cephalon,s illegal conduct.  ...
Breaking Medicine Technology:Global Syphilis Testing Market is Expected to Reach $3.6 Billion, by 2020 - Allied Market Research 2Global Syphilis Testing Market is Expected to Reach $3.6 Billion, by 2020 - Allied Market Research 3Citizens Rx Addresses Recent PBM Consolidation and Rising Pharmacy Costs 2Citizens Rx Addresses Recent PBM Consolidation and Rising Pharmacy Costs 3FTC Settlement of Cephalon Pay for Delay Case Ensures $1.2 Billion in Ill-Gotten Gains Relinquished; Refunds Will Go To Purchasers Affected By Anticompetitive Tactics 2FTC Settlement of Cephalon Pay for Delay Case Ensures $1.2 Billion in Ill-Gotten Gains Relinquished; Refunds Will Go To Purchasers Affected By Anticompetitive Tactics 3
Cached News: